Martin Delle

Dr. Martin Delle

orcid

Research Focus & Metrics

Academic Career Length

35Years (1992-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 November 2018 in Abdominal Radiology
Verified
Journal Article
Closed access
PDF file
VCVincenzo Carollo
Vincenzo Carollo
GMGianluca Marrone
Gianluca Marrone
KCKelvin Cortis
Kelvin Cortis
GMGiuseppe Mamone
Giuseppe Mamone
SCSettimo Caruso
Settimo Caruso
JGJean de Ville de Goyet
Jean de Ville de Goyet

1 June 1992 in Acta Physiologica Scandinavica
Verified
Journal Article
Closed access
PDF file
SCS. Carlsson
S. Carlsson
JSJ. O. Skarphedinsson
J. O. Skarphedinsson
MDMartin Delle
Martin Delle
PHP. Hoffman
P. Hoffman
PTP. Thorén
P. Thorén

22 October 2023 in Heliyon
Verified
Journal Article
Open access
DBDennis Björk
Dennis Björk
MDMartin Delle
Martin Delle
FHFredrik Holmquist
Fredrik Holmquist
KHKristina Hasselgren
Kristina Hasselgren
PSPer Sandstrom
Per Sandstrom
BBBergthor Björnsson
Bergthor Björnsson
An adequate future liver remnant (FLR) is fundamental for major liver resections. To achieve sufficient FLR, portal vein embolization (PVE) may be used. The most effective material for PVE has yet to be determined. The aim of this study was to investigate the differences in FLR growth between n-butyl-cyanoacrylate glue (NBCA) and microparticles. retrospective study was performed at three Swedish hepatobiliary centers and included patients who underwent PVE 2013–2021. Electronic medical records were reviewed, and procedure-related data were collected. Data were analyzed with respect to embolizing material. A total of 265 patients were included: 160 in the NBCA group and 105 in the microparticle group. The NBCA group had a higher degree of hypertrophy (12.1 vs. 9.4 % points, p = 0.003) and a higher resection rate (68 vs. 59 %, p = 0.01) than the microparticle group. Procedure-related data all indicated the superiority of NBCA. No difference in inducing hypertrophy was observed when comparing patients who received chemotherapy before PVE with those who received chemotherapy before and after PVE within the NBCA group. This retrospective multicenter study supports the superiority of NBCA compared to microparticles in the setting of PVE. Chemotherapy after PVE does not seem to negatively affect hypertrophy.

1 August 2011 in Annals of Vascular Surgery
Verified
Journal Article
Closed access
PDF file
PGPeter Gillgren
Peter Gillgren
HPHans Pettersson
Hans Pettersson
JFJohan Fernström
Johan Fernström
MFMårten Falkenberg
Mårten Falkenberg
MDMartin Delle
Martin Delle
DLDavid Lindström
David Lindström

10 September 2024 in Current Oncology
Verified
Journal Article
Open access
PDF file
GZGalyna Zinko
Galyna Zinko
MHMarianna Hrebenyuk
Marianna Hrebenyuk
AKAnders Urospeed 2 Kjellman
Anders Urospeed 2 Kjellman
YFYngve Forslin
Yngve Forslin
MDMartin Delle
Martin Delle
The purpose of this study was to examine the factors influencing the efficacy and safety of the ultrasound-guided radiofrequency ablation of renal tumors. Between January 2010 and December 2018, 159 patients with renal tumors treated with ultrasound-guided percutaneous radiofrequency ablation at our institution were included in this study. Biopsies were performed for histopathological analysis prior to each ablation. Patients underwent computed tomography follow-ups at 3, 6, and 12 months and were subsequently observed on an annual basis. The primary efficacy rate (i.e., residual tumor), local tumor progression, morbidity and mortality, and possible outcome predictors (age, body mass index, gender, tumor size, tumor location, tumor characteristics, ablation temperature, and reported technical problems) were analyzed using binary logistic regression. At the first follow-up, 3 months after ablation, the primary efficacy rate was 79%. Two percent of the tumors showed local tumor progression during the whole follow-up. Tumor proximity to the collecting system and the final temperature in the ablation region were associated with the occurrence of residual tumor (OR = 2.85, p = 0.019 and OR = 4.23, p = 0.006, respectively). A similar trend was shown for tumors larger than 3 cm (p = 0.066). A short distance to the collecting system and the ablation temperature were significantly related to the occurrence of residual tumors after the radiofrequency ablation of small renal masses. The ultrasound guidance used in our study has a lower primary efficacy rate than the computed tomography guidance used in comparable studies.

25 July 2026 in Radiology Case Reports
Verified
Journal Article
Open access
YFYngve Forslin
Yngve Forslin
DPDavid Andrei Patrauceanu
David Andrei Patrauceanu
MVMaria Vinell
Maria Vinell
ONOctavian Petru Nitescu
Octavian Petru Nitescu
ANAlexia Maria Neagu
Alexia Maria Neagu
MDMartin Delle
Martin Delle